Glucagon-like Peptide-1 Analog

Weekly GLP-1 Analog Improves Glycemic Control vs Glargine in T2D Inadequately Controlled on Metformin

Weekly GLP-1 Analog Improves Glycemic Control vs Glargine in T2D Inadequately Controlled on Metformin

By

A phase 3a trial evaluates whether the novel glucagon-like peptide-1 analog semaglutide substantially improved glycemic control compared with insulin glargine in patients with type 2 diabetes inadequately controlled with metformin.

Sign Up for Free e-Newsletters



CME Focus